Camurus
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
CAMX | ST
Overview
Corporate Details
- ISIN(s):
- SE0007692850 (+2 more)
- LEI:
- 5493003S6Z6VI7WYFQ06
- Country:
- Sweden
- Address:
- Ideon Science Park, 223 70 Lund
- Website:
- https://www.camurus.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Camurus is a science-led international biopharmaceutical company focused on developing and commercializing innovative, long-acting medicines for severe and chronic diseases. Leveraging its expertise in advanced drug delivery systems, the company aims to improve treatment outcomes and quality of life for patients. Camurus' development pipeline and commercial products target significant unmet medical needs in therapeutic areas including diseases of the central nervous system, rare diseases, endocrinology, oncology, and supportive care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 07:00 |
Regulatory News Service
Valberedning utsedd inför Camurus årsstämma 2026
|
Swedish | 149.2 KB | ||
| 2025-11-13 07:00 |
Regulatory News Service
Camurus’ Nomination Committee appointed for the Annual General Meeting 2026
|
English | 151.9 KB | ||
| 2025-11-10 08:00 |
Earnings Release
Camurus reports positive topline results for CAM2056, semaglutide monthly depot
|
English | 213.9 KB | ||
| 2025-11-10 08:00 |
Earnings Release
Camurus rapporterar positiva resultat för CAM2056, semaglutid månadsdepå
|
Swedish | 188.3 KB | ||
| 2025-11-06 07:00 |
Quarterly Report
|
Swedish | 1.0 MB | ||
| 2025-11-06 07:00 |
Quarterly Report
|
English | 857.9 KB | ||
| 2025-09-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Förändring av antalet aktier och röster i Camurus
|
Swedish | 134.6 KB | ||
| 2025-09-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Camurus
|
English | 136.1 KB | ||
| 2025-07-17 07:00 |
Earnings Release
|
Swedish | 923.9 KB | ||
| 2025-07-17 07:00 |
Quarterly Report
|
English | 916.2 KB | ||
| 2025-07-01 11:30 |
Regulatory News Service
Camurus’ Oczyesa® receives marketing authorization for treatment of acromegaly …
|
English | 184.9 KB | ||
| 2025-07-01 11:30 |
Earnings Release
Camurus meddelar EU-godkännande av Oczyesa® för behandling av akromegali
|
Swedish | 182.4 KB | ||
| 2025-06-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Förändring av antalet aktier och röster i Camurus
|
Swedish | 130.6 KB | ||
| 2025-06-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Camurus
|
English | 141.7 KB | ||
| 2025-06-18 08:00 |
Regulatory News Service
Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic live…
|
English | 168.7 KB |
Automate Your Workflow. Get a real-time feed of all Camurus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Camurus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Camurus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-17 | Torsten Malmström | Other | Sell | 10,000 | 6,806,400.00 SEK |
| 2024-06-17 | Jon Uguzne Garay Alonso | Other | Other | 33,750 | N/A |
| 2024-05-14 | Torsten Malmström | Other | Sell | 1,495 | 844,675.00 SEK |
| 2024-05-10 | Annette Mattsson | Other | Sell | 1,000 | 550,000.00 SEK |
| 2023-12-15 | Annette Mattsson | Other | Other | 1,000 | 169,500.00 SEK |
| 2023-09-18 | Annette Mattsson | Other | Sell | 1,000 | 294,600.00 SEK |
| 2023-09-06 | Maria Lundqvist | Other | Other | 381 | N/A |
| 2023-08-23 | Maria Lundqvist | Other | Sell | 77 | 22,610.28 SEK |
| 2023-08-23 | Maria Lundqvist | Other | Sell | 58 | 17,032.86 SEK |
| 2023-08-23 | Maria Lundqvist | Other | Other | 77 | 13,051.50 SEK |
Peer Companies
